Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Bruker Corporation before investing.
In this article, we go over a few key elements for understanding Bruker Corporation’s stock price such as:
- Bruker Corporation’s current stock price and volume
- Why Bruker Corporation’s stock price changed recently
- Upgrades and downgrades for BRKR from analysts
- BRKR’s stock price momentum as measured by its relative strength
About Bruker Corporation
(BRKR)
Before we jump into Bruker Corporation’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.
Bruker Corporation is a developer, manufacturer and distributor of scientific instruments and analytical and diagnostic solutions. The Company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano and Bruker Energy & Supercon Technologies (BEST). The BSI BioSpin segment designs, manufactures, and distributes enabling life science tools based on magnetic resonance technology. The BSI CALID segment designs, manufactures and distributes life science mass spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. The BSI Nano segment designs, manufactures and distributes advanced X-ray instruments, atomic force microscopy instrumentation, advanced fluorescence optical microscopy instruments, and others. BEST segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare, and big science research.
Want to learn more about Bruker Corporation’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Bruker Corporation.
Bruker Corporation’s Stock Price as of Market Close
As of November 06, 2023, 4:00 PM, CST, Bruker Corporation’s stock price was $56.15.
Bruker Corporation is down 4.54% from its previous closing price of $58.82.
During the last market session, Bruker Corporation’s stock traded between $56.50 and $59.48. Currently, there are 146.80 million shares of Bruker Corporation stock available for purchase.
Bruker Corporation’s price-earnings (P/E) ratio is currently at 27.2, which is low compared to the Advanced Medical Equipment & Technology industry median of 28.5. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.
Bruker Corporation Stock Price History
Bruker Corporation’s
(BRKR) price is currently down 1.49% so far this month.
During the month of November, Bruker Corporation’s stock price has reached a high of $60.53 and a low of $55.12.
Over the last year, Bruker Corporation has hit prices as high as $84.84 and as low as $53.79. Year to date, Bruker Corporation’s stock is down 33.08%.
Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions
What Caused Bruker Corporation Stock’s Price to Dip?
Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?
When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of November 03, 2023, there were 8 analysts who downgraded Bruker Corporation’s stock and 0 analysts who upgraded over the last month.
Additionally, you'll want to evaluate Bruker Corporation’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Bruker Corporation’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.
Bruker Corporation’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.
Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.
Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Bruker Corporation
(BRKR) by visiting AAII Stock Evaluator.
Relative Price Strength of Bruker Corporation
Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.
For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.
As of November 03, 2023, Bruker Corporation has a weighted four-quarter relative price strength of -5.71%, which translates to a Momentum Score of 47 and is considered to be Average.
Want to learn more about how Bruker Corporation is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.
Bruker Corporation Stock Price: Bottom Line
As of November 6, 2023, Bruker Corporation’s stock price is $56.15, which is down 4.54% from its previous closing price.
AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Bruker Corporation stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.
Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.
Included With AAII Platinum
at only 23.3%
Since Inception. Data as of 12/31/2024.
769.3% Stock Superstars Portfolio Total Return Since Inception
U.S. Index ETF (IYY)
SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.
FREE REPORT
BECOME A MEMBER FOR ONLY $2
Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.